Douglas J. Williamson - Executive VP, Research & Dev at ACADIA PHARMACEUTICALS INC

Issuer-level insider activity

Role
Executive VP, Research & Dev
Issuer ticker
ACAD on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Douglas J. Williamson since 13 Aug 2025

Reported holdings for Douglas J. Williamson in ACADIA PHARMACEUTICALS INC

Form 4 holding Executive VP, Research & Dev

ACADIA PHARMACEUTICALS INC

Security class
Restricted Stock Units
Shares / value
50,655
Estimated value
$1,517,624
Report date
10 Feb 2023
Price
$29.96
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Executive VP, Research & Dev

ACADIA PHARMACEUTICALS INC

Security class
Non-Qualified Stock Option (Right to Buy)
Shares / value
237,296
Estimated value
Report date
10 Feb 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Douglas J. Williamson in ACADIA PHARMACEUTICALS INC

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .